Discovery Life Sciences has significantly expanded its Discovery Partners Clinical Research network, which identifies patients for high value, next-generation medical device clinical trials and that can contribute proprietary products directly to its Magellan open-access biorepository.
Read More
A large clinical experience study has evaluated the performance of the Panorama noninvasive prenatal test from Natera Inc.
Read More
New clinical research suggests exhaled breath could be the future of drug testing.
Read More
Illumina is the primary vendor for variant interpretation and reporting software for tumor and matched normal samples characterized as part of the UK’s 100,000 Genomes Project.
Read More
With connectivity, point-of-care testing is on the front line when it comes to diagnosing and managing chronic diseases.
Read More